Treatment and survival of resected and unresected distal cholangiocarcinoma: a nationwide study

Belkouz, A.; Besselink, M.G. (Marc); de Reuver, P.R.; de Vos-Geelen, J; Groot Koerkamp, B. (Bas); Gulik, T.M. (Thomas) van; Hooft, J.E. (Jeanin) van; Klümpen, H.J. (Heinz Josef); Meijer, V.E. (Vincent) de; Mohammad, NH; Strijker, M.; van der Geest, L.G.; Verheij, J; Wilmink, JW

Treatment and survival of resected and unresected distal cholangiocarcinoma: a nationwide study

Authors: A. Belkouz
M.G. (Marc) Besselink
P.R. de Reuver
J de Vos-Geelen
B. (Bas) Groot Koerkamp
T.M. (Thomas) van Gulik
J.E. (Jeanin) van Hooft
H.J. (Heinz Josef) Klümpen
V.E. (Vincent) de Meijer
NH Mohammad
M. Strijker
L.G. van der Geest
J Verheij
JW Wilmink
Publication date: 1 January 2019
Publisher: 'Informa UK Limited'
Doi

Abstract

Background: Population-based data on distal cholangiocarcinoma (DCC) from the Western world are not available, albeit essential to identify areas for improvement. This study investigated the incidence, treatment and outcomes, including time trends and predictors for survival, in a nationwide cohort of DCC. Methods: This is a retrospective cohort study of patients diagnosed with DCC (2009–2016) derived from the Netherlands Cancer Registry. Overall survival (OS) and its predictors were analyzed using Kaplan–Meier and Cox regres